Introduction: Brain-derived neurotrophic factor (BDNF) has been involved in the pathogenesis of bipolar mood disorder and in the mechanism of mood-normalizing action of lithium. The aim of this study was to find a possible association between lithium prophylactic effect in bipolar patients and two polymorphisms of BDNF gene. Methods: Eighty-eight patients (35 males, 53 females) with bipolar illness were studied. Duration of lithium prophylaxis ranged between 5-27 years (mean 15 years). Three categories of prophylactic lithium response were delineated: excellent responders (ER), partial responders (PR) and non-responders (NR). All patients were genotyped for two polymorphisms of BDNF gene: Val66Met and -270C/T. Results: The Val/Met genotype of Val66Met polymorphism occurred more frequently (p = 0.037) and there was a trend for a higher incidence of Met allele (p = 0.076), in ER than in NR. A trend for C/T genotype and T allele of -270C/T polymorphism was observed to occur more frequently in ER than in NR (p = 0.057 and p = 0.065, respectively). Conclusion: The data obtained suggest that polymorphism of BDNF gene may be connected with a quality of lithium prophylaxis.
References
-
1
Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé A A.
Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in rat model of depression.
Int J Neuropsychopharmacol.
2003;
6
225-231
-
2
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N. et al .
Characterization of single-nucleotide polymorphisms in coding regions of human genes.
Nat Genet.
1999;
22
231-238
-
3
Egan M, Kojima M, Callicot J H, Goldberg T E, Kolachana B S, Bertolino A. et al .
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
Cell.
2003;
112
257-269
-
4
Fukumoto T, Morinobu S, Okamoto Y, Kahaya A, Yamawaki S.
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain.
Psychopharmacology.
2001;
158
100-106
-
5
Geller B, Badner J A, Tillman R, Christian S L, Bolhofner K, Cook EH J r.
Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype.
Am J Psychiatry.
2004;
161
1698-1700
-
6
Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang D M.
Lithium induces brain-derived neurotrophic factor and activities TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate neurotoxicity.
Neuropharmacology.
2002;
43
1173-1179
-
7
Hashimoto K, Shimizu E, Iyo M.
Critical role of brain-derived neurotrophic factor in mood disorders.
Brain Res Brain Res Rev.
2004;
45
104-114
-
8
Holoubek G, Noldner M, Treiber K, Muller W E.
Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction cascade.
Which effect matters most? Pharmacopsychiatry.
2004;
37 (Suppl 2)
S113-119
-
9
Hong C J, Huo S J, Yen F C, Tung C L, Pan G M, Tsai S J.
Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.
Neuropsychobiology.
2003;
48
86-189
-
10
Jacobsen J P, Mork A.
The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.
Brain Res.
2004;
1024
183-192
-
11
Kunugi H, Ueki M, Otsuga M, Isse K, Hirasawa H, Kato N. et al .
A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease.
Mol Psychiatry.
2001;
6
83-86
-
12
Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T. et al .
No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.
Biol Psychiatry.
2004;
56
376-378
-
13
Lu B.
BDNF and activity-dependent synaptic modulation.
Learn Mem.
2003;
10
86-98
-
14
Manji H K, Zarate C A.
Molecular and cellular mechanism underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.
Mol Psychiatry.
2002;
7
S1-S7
-
15
Miller S A, Dykaes D D, Polesky H F.
A simple salting out procedure for extracting DNA from human nucleated cells.
Nucleic Acid Res.
1988;
16
1215
-
16
Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T. et al .
Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder.
Neurosci Lett.
2003;
337
17-20
-
17
Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy J L.
The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.
Am J Hum Genet.
2002;
71
651-655
-
18
Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C. et al .
Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study.
Am J Med Genet.
2004;
129B
34-35
-
19
Proschel M, Saunders A, Roses A D, Muller C R.
Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF).
Hum Mol Genet.
1992;
1
353
-
20
Rowe M K, Chuang D M.
Lithium neuroprotection: molecular mechanisms and clinical implications.
Expert Rev Mol Med.
2004;
6
1-18
-
21
Rybakowski J K, Borkowska A, Czerski P M, Skibińska M, Hauser J.
Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients.
Bipolar Disord.
2003;
5
468-472
-
22 Rybakowski J K, Suwalska A, Czerski P M, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pol J Pharmacol 2004: (in press)
-
23
Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E.
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
Pharmacogenomics J.
2001;
1
71-77
-
24
Siuciak J A, Lewis D R, Wiegand S J, Lindsay R M.
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
Pharmacol Biochem Behav.
1997;
56
131-137
-
25
Skibińska M, Hauser J, Czerski P M, Leszczyńska-Rodziewicz A, Kosmowska M, Kapelski P. et al .
Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder.
World J Biol Psychiatry.
2004;
5
215-220
-
26
Sklar P, Gabriel S B, McInnis M G, Bennet P, Lim Y M, Tsan G. et al .
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus.
Mol Psychiatry.
2002;
7
579-593
-
27
Strauss J, Barr C L, George C J, King N, Shaikh S, Devlin B. et al .
Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder.
Am J Med Genet..
2004;
131B
16-19
-
28 Szczepankiewicz A, Skibinska M, Czerski P M, Kapelski P, Leszczynska-Rodziewicz A, Slopien A. et al .No association of the Brain-Derived Neurotrophic Factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr Res 2005: (in press)
-
29
Tsai S -J, Hong C -J, Yu Y W-Y, Chen T -J.
Association study of a brain-derived neurotrophic factor (BDNF) Val66met polymorphism and personality trait and intelligence in healthy young females.
Neuropsychobiol.
2004;
49
13-16
-
30
Turecki G, Grof P, Grof E, D’Souza V, Lebuis L, Marineau C. et al .
Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium.
Mol Psychiatry.
2001;
6
570-578
-
31
Tyler W J, Alonso M, Bramham C R, Pozzo-Miller L D.
From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning.
Learn Mem.
2002;
9
224-237
-
32
Yamada K, Mizuno M, Nabeshima T.
Role for brain-derived neurotrophic factor in learning and memory.
Life Sci.
2002;
70
735-744
Prof. Dr. Janusz K. Rybakowski
Department of Adult Psychiatry
University of Medical Sciences
ul.Szpitalna 27/33
60-572 Poznan
Poland
Telefon: +48 61 8475 087
Fax: +48 61 8480 392
eMail: rybakows@wlkp.top.pl